Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6479]

ASH 2011: Cereblon expression is required for the anti-myeloma activity of lenalidomide and pomalidomide

ASH 2011: Cereblon expression is required for the anti-myeloma activity of lenalidomide and pomalidomide

ASH 2011: B-cell depletion, remissions of malignancy, and cytokine-associated toxicity in a clinical trial of T-cells genetically-engineered to express an anti-CD19 chimeric antigen receptor

ASH 2011: B-cell depletion, remissions of malignancy, and cytokine-associated toxicity in a clinical trial of T...

White adipose tissue used in lipotransfer can promote cancer progression

White adipose tissue used in lipotransfer can promote cancer progression

Ubiquitin-mediated proteolysis pathway genes mutated in clear cell renal cell carcinoma

Ubiquitin-mediated proteolysis pathway genes mutated in clear cell renal cell carcinoma

SABCS 2011: Addition of bevacizumab to conventional therapy improved progression-free survival in HER2-positive breast cancer

SABCS 2011: Addition of bevacizumab to conventional therapy improved progression-free survival in HER2-positive...

Ovarian cancer 'not detectable' in the blood for years

Ovarian cancer 'not detectable' in the blood for years

Serum levels of trefoil factor family proteins for gastric cancer screening

Serum levels of trefoil factor family proteins for gastric cancer screening

Mass General Hospital Cancer Center and Vall d'Hebron Institute of Oncology combine forces in biomarker alliance

Mass General Hospital Cancer Center and Vall d'Hebron Institute of Oncology combine forces in biomarker alliance

How to defeat tamoxifen resistance

How to defeat tamoxifen resistance

Combination therapy shows potent tumour growth inhibition in preclinical studies

Combination therapy shows potent tumour growth inhibition in preclinical studies

More from ecancer